{"id":17694,"date":"2022-01-20T12:05:47","date_gmt":"2022-01-20T12:05:47","guid":{"rendered":"https:\/\/zeepedia.com\/?p=17694"},"modified":"2022-01-21T13:36:53","modified_gmt":"2022-01-21T13:36:53","slug":"metalyse","status":"publish","type":"post","link":"https:\/\/zeepedia.com\/medical\/medicines\/metalyse\/","title":{"rendered":"Metalyse &#8211; Tenecteplas uses, dose and side effects"},"content":{"rendered":"\n<p>8,000 units of powder and solvent for solution for injection<br>tenecteplase<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What Metalyse is and what it is used for<\/h2>\n\n\n\n<p>Metalysis, powder, and solvent for solution for\u00a0injection.\u00a0Each package contains:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>1&nbsp;vial&nbsp;containing 8,000 units of Metalyse powder and 1 pre-filled&nbsp;syringe&nbsp;containing 8 ml of water for injections<\/li><\/ul>\n\n\n\n<p>Before use, the liquid (water for injections) should be added to the powder to obtain a solution, which is given as an\u00a0injection.<\/p>\n\n\n\n<p>Metalysis belongs to a group of drugs called thrombolytic agents.\u00a0These drugs facilitate the dissolution of blood clots.\u00a0Tenecteplase is a\u00a0recombinant\u00a0fibrin-specific plasminogen activator.<\/p>\n\n\n\n<p>Metalysis is used to treat a heart attack (heart attack) within 6 hours after the onset of symptoms and facilitates the dissolution of blood clots that form in the blood vessels of the heart.&nbsp;This counteracts damage caused by the heart attack and it has been shown that you can save lives.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">What you need to know before using Metalyse<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Do not use Metalyse<\/h2>\n\n\n\n<p><strong>Your doctor will not give Metalyse:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if you have previously had a sudden, life-threatening&nbsp;allergic reaction&nbsp;(severe hypersensitivity) to the active substance tenecteplas, to gentamicin (a trace element remaining from the manufacturing process), or to any of the other ingredients of Metalyse.&nbsp;If treatment with Metalyse is still considered necessary, resuscitation equipment should be readily available if necessary;<\/li><li>if you have or have recently had a disease with an increased risk of bleeding, for example:<\/li><\/ul>\n\n\n\n<p>bleeding disorders or tendency to bleed<\/p>\n\n\n\n<p>stroke&nbsp;(&nbsp;cerebrovascular&nbsp;disease&nbsp;)<\/p>\n\n\n\n<p>&#8211; very high, uncontrolled&nbsp;blood pressure<\/p>\n\n\n\n<p>head injury<\/p>\n\n\n\n<p>&#8211; severe liver disease<\/p>\n\n\n\n<p>&#8211;&nbsp;stomach ulcer<\/p>\n\n\n\n<p>varicose veins in the esophagus<\/p>\n\n\n\n<p>&#8211; malformations in the blood vessels (eg&nbsp;aneurysm&nbsp;)<\/p>\n\n\n\n<p>&#8211; some&nbsp;tumors&nbsp;you<\/p>\n\n\n\n<p>&#8211;&nbsp;inflammation&nbsp;of the pericardium (pericarditis);&nbsp;inflammation&nbsp;or&nbsp;infection&nbsp;of the heart valves (&nbsp;endocarditis&nbsp;)<\/p>\n\n\n\n<p>&#8211; dementia;<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if you are taking medicines to thin the blood, such as&nbsp;warfarin&nbsp;or coumarin (&nbsp;anticoagulants&nbsp;);<\/li><li>if you have&nbsp;inflammation&nbsp;of the pancreas (&nbsp;pancreatitis&nbsp;);<\/li><li>if you have recently undergone major surgery on your brain or spine;<\/li><li>if you have undergone cardiopulmonary resuscitation (compression of the chest) for more than 2 minutes, during the last two weeks;<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Warnings and cautions<\/h2>\n\n\n\n<p><strong>Your doctor will be especially careful with Metalyse<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>if you have had an&nbsp;allergic reaction&nbsp;other than a sudden, life-threatening&nbsp;allergic reaction&nbsp;(severe hypersensitivity) to the active substance tenecteplase, to gentamicin (a trace element remaining from the manufacturing process), or to any of the other ingredients of Metalyse (listed in section 6, Packaging) content and other information):<\/li><li>if you have high blood pressure;<\/li><li>if you have problems with blood circulation in the brain (&nbsp;cerebrovascular&nbsp;disease);<\/li><li>if you have had bleeding from the gastrointestinal tract, reproductive organs or urinary tract in the last 10 days (this may cause blood in the stool or urine);<\/li><li>if you have malformations of the heart valves (eg&nbsp;mitral stenosis&nbsp;) with abnormal heart rhythm (eg&nbsp;atrial fibrillation&nbsp;);<\/li><li>if you have had an&nbsp;intramuscular&nbsp;injection&nbsp;in the last two days;<\/li><li>if you are older than 75 years;<\/li><li>if you weigh less than 60 kg.<\/li><li>if you have received Metalyse before.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Children and young people<\/h2>\n\n\n\n<p>The use of Metalyse is not recommended for children and adolescents under 18 years of age.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Other drugs and Metalyse<\/h2>\n\n\n\n<p>Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Pregnancy, breastfeeding and fertility<\/h2>\n\n\n\n<p>If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before using this medicine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to use Metalyse<\/h2>\n\n\n\n<p>Your doctor will calculate the\u00a0dose\u00a0so that it is adapted to your body weight, based on the following table:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><th scope=\"col\"><strong>Body weight (kg)<\/strong><\/th><th scope=\"col\"><strong>under 60<\/strong><\/th><th scope=\"col\"><strong>60 to 70<\/strong><\/th><th scope=\"col\"><strong>70 to 80<\/strong><\/th><th scope=\"col\"><strong>80 to 90<\/strong><\/th><th scope=\"col\"><strong>over 90<\/strong><\/th><\/tr><tr><td>Metalyse (Units)<\/td><td>6,000<\/td><td>7,000<\/td><td>8,000<\/td><td>9,000<\/td><td>10,000<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\"><li>In addition to the treatment with Metalyse, your doctor will give you medicines that counteract&nbsp;coagulation&nbsp;of the blood as soon as possible after you feel chest pain.<\/li><li>Metalysis is given as a single&nbsp;injection&nbsp;into a vein by a doctor who has experience using this type of medicine.<\/li><li>Your doctor will give Metalyse as a single&nbsp;injection&nbsp;as soon as possible after you feel chest pain.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Possible side effects<\/h2>\n\n\n\n<p>Like all medicines, this medicine can cause\u00a0side effects, although not everybody gets them.<\/p>\n\n\n\n<p>The following side effects&nbsp;have been reported in people treated with Metalyse:<\/p>\n\n\n\n<p>Very common (may affect more than 1 user in 10):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>bleeding<\/li><\/ul>\n\n\n\n<p>Common (may affect up to 1 in 10 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>bleeding at the injection site or sampling site<\/li><li>nosebleed<\/li><li>bleeding from the reproductive organs or urinary tract (you can see blood in the urine)<\/li><li>bruises<\/li><li>gastrointestinal&nbsp;bleeding (eg bleeding from the stomach or intestines)<\/li><\/ul>\n\n\n\n<p>Uncommon (may affect up to 1 in 100 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>irregular heartbeat (reperfusion arrhythmia) which sometimes leads to cardiac arrest.&nbsp;Cardiac arrest can be life-threatening.<\/li><li>internal bleeding in the abdomen (retroperitoneal bleeding)<\/li><li>bleeding in the brain (cerebral hemorrhage).&nbsp;Death or permanent disability can occur after bleeding in the brain and other severe bleeding<\/li><li>bleeding in the eye<\/li><\/ul>\n\n\n\n<p>Rare (may affect up to 1 in 1,000 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>low&nbsp;blood pressure&nbsp;(&nbsp;hypotension&nbsp;)<\/li><li>pulmonary&nbsp;haemorrhage&nbsp;(&nbsp;pulmonary&nbsp;haemorrhage)<\/li><li>hypersensitivity (anaphylactoid reaction) eg rash,&nbsp;hives&nbsp;(&nbsp;urticaria&nbsp;), difficulty breathing (bronchospasm)<\/li><li>hemorrhage (haemopericardium)<\/li><li>blood clots in the lung (&nbsp;pulmonary embolism&nbsp;) and in the blood vessels of other organ systems (thrombotic embolization)<\/li><\/ul>\n\n\n\n<p>No known frequency (frequency can not be calculated from available data):&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>fat embolism (plugs consisting of fat)<\/li><li>nausea<\/li><li>vomiting<\/li><li>increased body temperature (fever)<\/li><li>blood transfusion&nbsp;due to bleeding<\/li><\/ul>\n\n\n\n<p>As with other anticoagulant drugs, the following events have been reported as a result of myocardial infarction and\/or treatment with anticoagulants:<\/p>\n\n\n\n<p>Very common (may affect more than 1 user in 10)&nbsp;<strong>:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>low&nbsp;blood pressure&nbsp;(&nbsp;hypotension&nbsp;)<\/li><li>irregular heartbeats<\/li><li>chest pain (&nbsp;angina pectoris&nbsp;)<\/li><\/ul>\n\n\n\n<p>Common (may affect up to 1 in 10 people)&nbsp;<strong>:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>renewed chest pain \/ angina (reindeer infarction)<\/li><li>myocardial infarction<\/li><li>heart failure<\/li><li>shock&nbsp;due to&nbsp;heart failure<\/li><li>inflammation&nbsp;of the pericardium<\/li><li>fluid in the lungs (&nbsp;pulmonary edema&nbsp;)<\/li><\/ul>\n\n\n\n<p>Uncommon (may affect up to 1 in 100 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>cardiac arrest<\/li><li>problems with heart valves or pericardium (mitral regurgitation, pericardial effusion)<\/li><li>blood clots in the veins (&nbsp;venous thrombosis&nbsp;)<\/li><li>fluid between the heart and the pericardium (&nbsp;cardiac tamponade&nbsp;)<\/li><li>myocardial rupture (myocardial rupture)<\/li><\/ul>\n\n\n\n<p>Rare (may affect up to 1 in 1,000 people):<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>blood clot in the lung (&nbsp;pulmonary embolism&nbsp;)<\/li><\/ul>\n\n\n\n<p>These cardiovascular events can be life-threatening and can lead to death.<\/p>\n\n\n\n<p>In patients with cerebral hemorrhage,\u00a0side effects\u00a0from the nervous system have been reported, such as drowsiness (\u00a0somnolence\u00a0), speech disorders, paralysis of parts of the body (hemiparesis), and convulsions (convulsions).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How to store Metalyse<\/h2>\n\n\n\n<p>Keep this medicine out of the sight and reach of children.<\/p>\n\n\n\n<p>Do not use this medicine after the expiry date which is stated on the label and carton after EXP.<\/p>\n\n\n\n<p>Do not store above 30 \u00b0 C.<\/p>\n\n\n\n<p>Store in the outer carton.&nbsp;Sensitive to light.<\/p>\n\n\n\n<p>Once the liquid has been added to the Metalyse powder, the reconstituted liquid can be stored for 24 hours at 2 &#8211; 8 \u00b0 C and 8 hours at 30 \u00b0 C.&nbsp;However, for microbiological reasons, your doctor will normally use the reconstituted solution immediately.<\/p>\n\n\n\n<p>Medicines should not be disposed of via wastewater or household waste.&nbsp;Ask your pharmacist how to dispose of medicines no longer required.&nbsp;These measures will help to protect the environment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Contents of the pack and other information<\/h2>\n\n\n\n<h2 class=\"wp-block-heading\">Content declaration<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>The active substance is tenecteplase.&nbsp;Each&nbsp;vial&nbsp;contains 8,000 units (40 mg) of tenecteplase.&nbsp;Each pre-filled&nbsp;syringe&nbsp;contains 8 ml of liquid.&nbsp;After&nbsp;reconstitution&nbsp;with 8 ml of liquid, each milliliter contains 1,000 units of tenecteplase.<\/li><li>The other ingredients are L-&nbsp;arginine&nbsp;,&nbsp;phosphoric acid&nbsp;, polysorbate 20.<\/li><li>The liquid is water for injections.<\/li><li>Gentamicin is included as a trace residue that remains from the manufacturing process.<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">What the medicine looks like and contents of the pack<\/h2>\n\n\n\n<p>The carton contains a\u00a0vial\u00a0of lyophilized powder containing 40 mg tenecteplase, a pre-filled\u00a0syringe containing\u00a08 ml of liquid, an adapter for the vial,f and a needle.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Marketing Authorization Holder and Manufacturer<\/h2>\n\n\n\n<ul class=\"wp-block-list\"><li>Boehringer Ingelheim International GmbH<\/li><li>Binger Strasse 173<\/li><li>D-55216 Ingelheim am RheinGermany<\/li><\/ul>\n\n\n\n<p>Manufacturer<\/p>\n\n\n\n<p>Boehringer Ingelheim Pharma GmbH &amp; Co.&nbsp;KG<\/p>\n\n\n\n<p>Birkendorfer Strasse 65<\/p>\n\n\n\n<p>D-88397 Biberach \/ Riss<\/p>\n\n\n\n<p>Germany<\/p>\n\n\n\n<p>Boehringer Ingelheim France<\/p>\n\n\n\n<p>100-104 Avenue de France<\/p>\n\n\n\n<p>75013 Paris<\/p>\n\n\n\n<p>France<\/p>\n\n\n\n<p>Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td><br><strong>Belgium \/ Belgique \/ Belgien<\/strong>SCS Boehringer Ingelheim Comm.V<br>Tel: +32 2 773 33 11<\/td><td><br><strong>Lithuania<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KGLithuanian branchesTel: +370 5 2595942<\/td><\/tr><tr><td><strong>Bulgaria<\/strong>Boringer Inglehaim RIV Gemba and Co.&nbsp;K\u0413 &#8211; clone of BulgariaTel: +359 2 958 79 98<\/td><td><strong>Luxembourg \/ Luxemburg<\/strong>SCS Boehringer Ingelheim Comm.V<br>Tel: +32 2 773 33 11<\/td><\/tr><tr><td><strong>Czech Republic<\/strong>Boehringer Ingelheim spol.&nbsp;s roTel: +420 234 655 111<\/td><td><strong>Hungary<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KG Magyarorsz\u00e1gi Fi\u00f3ktelepe<br>Tel: +36 1 299 89 00<\/td><\/tr><tr><td><strong>Denmark<\/strong>Boehringer Ingelheim Danmark A \/ STel: +45 39 15 88 88<\/td><td><strong>Malta<\/strong>Boehringer Ingelheim Ireland Ltd.Tel: +353 1 295 9620<\/td><\/tr><tr><td><strong>Germany<\/strong>Boehringer Ingelheim Pharma GmbH &amp; Co.&nbsp;KGTel: +49 (0) 800 77 90 900<\/td><td><strong>The Netherlands<\/strong>Boehringer Ingelheim bvTel: +31 (0) 800 22 55 889<\/td><\/tr><tr><td><strong>Eesti<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KGEesti subsidiaryTel: +372 612 8000<\/td><td><strong>Norway<\/strong>Boehringer Ingelheim Norway KSTel: +47 66 76 13 00<\/td><\/tr><tr><td><strong>Greece<\/strong>Boehringer Ingelheim Ellas AET\u03b7\u03bb: +30 2 10 89 06 300<\/td><td><strong>Austria<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KGTel: +43 1 80 105-7870<\/td><\/tr><tr><td><strong>Spain<\/strong>Boehringer Ingelheim Espa\u00f1a, SATel: +34 93 404 51 00<\/td><td><strong>Poland<\/strong>Boehringer Ingelheim Sp.&nbsp;z ooTel: +48 22 699 0 699<\/td><\/tr><tr><td><strong>France<\/strong>Boehringer Ingelheim France SASTel: +33 3 26 50 45 33<\/td><td><strong>Portugal<\/strong>Boehringer Ingelheim, Unipessoal, Lda.Tel: +351 21 313 53 00<\/td><\/tr><tr><td><strong>Croatia<\/strong>Boehringer Ingelheim Zagreb dooTel: +385 1 2444 600<\/td><td><strong>Romania<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KG Viena &#8211; Sucursala Bucure\u015ftiTel: +40 21 302 28 00<\/td><\/tr><tr><td><strong>Ireland<\/strong>Boehringer Ingelheim Ireland Ltd.Tel: +353 1 295 9620<\/td><td><strong>Slovenia<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KG Podru\u017enica LjubljanaTel: +386 1 586 40 00<\/td><\/tr><tr><td><strong>Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td><td><strong>Slovak Republic<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co. KG Organizing ServicesTel: +421 2 5810 1211<\/td><\/tr><tr><td><strong>Italy<\/strong>Boehringer Ingelheim Italia SpATel: +39 02 5355 1<\/td><td><strong>Finland \/ Finland<\/strong>Boehringer Ingelheim Finland KyPuh \/ Tel: +358 10 3102 800<\/td><\/tr><tr><td><strong>.\u03a0\u03c1\u03bf\u03c2<\/strong>Boehringer Ingelheim Ellas AET\u03b7\u03bb: +30 2 10 89 06 300<\/td><td><strong>Sweden<\/strong>Boehringer Ingelheim ABTel: +46 8 721 21 00<\/td><\/tr><tr><td><strong>Latvia<\/strong>Boehringer Ingelheim RCV GmbH &amp; Co KGLatvian branchTel: +371 67 240 011<\/td><td><strong>United Kingdom<\/strong>Boehringer Ingelheim Ltd.Tel: +44 1344 424 600<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Metalysis, powder and solvent for solution for injection . Each package contains:<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2200,15580],"tags":[17193,17187,17188,17191,17192,17182,17185,17186,17189,17183,17190,17184],"class_list":["post-17694","post","type-post","status-publish","format-standard","hentry","category-medicines","category-m","tag-benefits-of-metalyse","tag-benefits-of-tenecteplas","tag-metalyse","tag-metalyse-injection","tag-metalyse-side-effects","tag-tenecteplas","tag-tenecteplas-injection","tag-tenecteplas-side-effects","tag-what-is-metalyse","tag-what-is-tenecteplas","tag-what-metalyse-is-used-for","tag-what-tenecteplas-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/17694","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=17694"}],"version-history":[{"count":4,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/17694\/revisions"}],"predecessor-version":[{"id":17729,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/17694\/revisions\/17729"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=17694"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=17694"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=17694"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}